Thalamonal en es it fr

Thalamonal Brand names, Thalamonal Analogs

Thalamonal Brand Names Mixture

  • No information avaliable

Thalamonal Chemical_Formula


Thalamonal RX_link

Thalamonal fda sheet

Thalamonal msds (material safety sheet)

Thalamonal MSDS

Thalamonal Synthesis Reference

No information avaliable

Thalamonal Molecular Weight

166.24 g/mol

Thalamonal Melting Point

No information avaliable

Thalamonal H2O Solubility

Appreciable as liquid hydrochloride salt

Thalamonal State


Thalamonal LogP


Thalamonal Dosage Forms

Liquid for injection

Thalamonal Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Thalamonal Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Thalamonal Absorption

Rapidly absorbed.

Thalamonal side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Thalamonal Patient Information

No information avaliable

Thalamonal Organisms Affected

Humans and other mammals